While many areas of the pharmaceutical industry will suffer from current economic conditions worldwide, sales of over-the-counter drugs are widely anticipated to grow as consumers seek cheaper alternatives.
This report contains market size and forecasts of Rx to OTC Switches in Global, including the following market information:
Global Rx to OTC Switches Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Rx to OTC Switches market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Analgesics Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Rx to OTC Switches include Bayer, C. H. Boehringer Sohn, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer and Sanofi, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Rx to OTC Switches companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Rx to OTC Switches Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Rx to OTC Switches Market Segment Percentages, by Type, 2021 (%)
Analgesics
Anti-infectives
Gastrointestinal Drugs
Others
Global Rx to OTC Switches Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Rx to OTC Switches Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Rx to OTC Switches Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Rx to OTC Switches Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Rx to OTC Switches revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Rx to OTC Switches revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bayer
C. H. Boehringer Sohn
GlaxoSmithKline
Johnson & Johnson
Merck
Novartis
Pfizer
Sanofi